Liminatus Pharma, Inc.
LIMN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001971387
No open-market purchases or sales by Liminatus Pharma, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $105.1K in total; no superinvestor holds it.
Other share classesLIMNW
Holders of 5% or more of LIMN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Liminatus Pharma, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Iris Acquisition Holdings LLC | 13D | 26.50%6.90M shares | New | May 8, 20251 filing | May 8, 2025 | SEC |
| Valetudo Therapeutics LLC | 13D | 23.70%6.17M shares | New | May 7, 20251 filing | May 7, 2025 | SEC |
| KH Feelux Co., Ltd | 13G | 15.40%4.00M shares | New | Jun 27, 20251 filing | Jun 27, 2025 | SEC |
| Ewon Comfortech Co., Ltd. | 13G | 5.80%1.50M shares | New | Jun 26, 20251 filing | Jun 26, 2025 | SEC |
| Red Peony Association 1st | 13G | 5.70%1.47M shares | New | Jun 26, 20251 filing | Jun 26, 2025 | SEC |
| Nongae Apple Association 1st | 13G | 5.70%1.47M shares | New | Jun 26, 20251 filing | Jun 26, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Liminatus Pharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 20264:15 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%2.07M shares | NewBelow 5% | Feb 17, 2026 | SEC |
| Jun 27, 20256:42 PM ET | KH Feelux Co., Ltd | 13G | 15.40%4.00M shares | New | Apr 30, 2025 | SEC |
| Jun 26, 20255:20 PM ET | Red Peony Association 1st | 13G | 5.70%1.47M shares | New | Apr 30, 2025 | SEC |
| Jun 26, 20255:19 PM ET | Ewon Comfortech Co., Ltd. | 13G | 5.80%1.50M shares | New | Apr 30, 2025 | SEC |
| Jun 26, 20255:19 PM ET | Nongae Apple Association 1st | 13G | 5.70%1.47M shares | New | Apr 30, 2025 | SEC |
| May 8, 20254:21 PM ET | Iris Acquisition Holdings LLC | 13D | 26.50%6.90M shares | New | Apr 30, 2025 | SEC |
| May 7, 20255:11 PM ET | Valetudo Therapeutics LLCand 1 other | 13D | 23.70%6.17M shares | New | Apr 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Liminatus Pharma, Inc. shares.
No Form 144 notices for Liminatus Pharma, Inc. are on file.